Search research articles
Contact Us
Filters
Showing results (231-240 of 830) with videos related to
Page
of 83
Sort By:
Neuroscience
|
November 9, 2000
Paradoxical activational effects of a corticotropin-releasing factor-binding protein "ligand inhibitor" in rat brain
R K Chan, W W Vale, P E Sawchenko
Biochemical and Biophysical Research Communications
|
April 15, 1992
Molecular cloning and binding properties of the human type II activin receptor
C J Donaldson, L S Mathews, W W Vale
Trends in Cardiovascular Medicine
|
February 15, 2003
A new role for corticotropin-releasing factor receptor-2: suppression of vascularization
Tracy L Bale, Frank J Giordano, Wylie W Vale
Regulatory Peptides
|
August 1, 1982
Pituitary somatostatin receptors: dissociation at the pituitary level of receptor affinity and biological activity for selective somatostatin analogs
J C Reubi, M Perrin, J Rivier, et al.
Brain Research
|
April 26, 1991
Distribution of corticotropin-releasing factor mRNA and immunoreactivity in the central auditory system of the rat
J Imaki, T Imaki, W Vale, et al.
Endocrinology
|
April 1, 1986
Ontogeny of the stress response in the rat: role of the pituitary and the hypothalamus
C D Walker, M Perrin, W Vale, et al.
The American Journal of Physiology
|
November 1, 1989
TRH-induced vagal stimulation of duodenal HCO-3 mediated by VIP and muscarinic pathways
H J Lenz, W W Vale, J E Rivier
Neurosciences Research Program Bulletin
|
June 1, 1978
Neurobiology of peptides
L L Iversen, R A Nicoll, W W Vale
Journal of Medicinal Chemistry
|
August 1, 1976
Tyrosylated analogues of somatostatin
J E Rivier, M R Brown, W W Vale
Acta Physiologica Scandinavica
|
May 1, 1985
Growth hormone releasing factor (GRF) and dopamine coexist in hypothalamic arcuate neurons
B Meister, T Hökfelt, W W Vale, et al.
Page
of 83
Search research articles
Search
Showing results (231-240 of 830) with videos related to
Sort By:
Page
of 83
Neuroscience
|
November 9, 2000
Paradoxical activational effects of a corticotropin-releasing factor-binding protein "ligand inhibitor" in rat brain
R K Chan, W W Vale, P E Sawchenko
Biochemical and Biophysical Research Communications
|
April 15, 1992
Molecular cloning and binding properties of the human type II activin receptor
C J Donaldson, L S Mathews, W W Vale
Trends in Cardiovascular Medicine
|
February 15, 2003
A new role for corticotropin-releasing factor receptor-2: suppression of vascularization
Tracy L Bale, Frank J Giordano, Wylie W Vale
Regulatory Peptides
|
August 1, 1982
Pituitary somatostatin receptors: dissociation at the pituitary level of receptor affinity and biological activity for selective somatostatin analogs
J C Reubi, M Perrin, J Rivier, et al.
Brain Research
|
April 26, 1991
Distribution of corticotropin-releasing factor mRNA and immunoreactivity in the central auditory system of the rat
J Imaki, T Imaki, W Vale, et al.
Endocrinology
|
April 1, 1986
Ontogeny of the stress response in the rat: role of the pituitary and the hypothalamus
C D Walker, M Perrin, W Vale, et al.
The American Journal of Physiology
|
November 1, 1989
TRH-induced vagal stimulation of duodenal HCO-3 mediated by VIP and muscarinic pathways
H J Lenz, W W Vale, J E Rivier
Neurosciences Research Program Bulletin
|
June 1, 1978
Neurobiology of peptides
L L Iversen, R A Nicoll, W W Vale
Journal of Medicinal Chemistry
|
August 1, 1976
Tyrosylated analogues of somatostatin
J E Rivier, M R Brown, W W Vale
Acta Physiologica Scandinavica
|
May 1, 1985
Growth hormone releasing factor (GRF) and dopamine coexist in hypothalamic arcuate neurons
B Meister, T Hökfelt, W W Vale, et al.
Page
of 83